EVERY CURE INC

Philadelphia, PA, US
501(c)3
EIN
92-0240717
Philadelphia, PA, US
501(c)3
EIN
92-0240717

Overview

Sign up for

Est.

2022

Fiscal Year Start

Jan 1

Organization Type

Grantseeker

Mission Statement

THE ORGANIZATION'S MISSION IS TO SAVE AND IMPROVE LIVES BY REPURPOSING DRUGS.
Revenues

$54.5M

Expenses

$7.4M

Net Income:
+$47M
Assets

$51.6M

Liabilities

$2.3M

Net Assets:
+$49.3M
Operating Budget

$5.3M

Operating Budget by Year

Due Diligence

Are you a grantmaker?
Charity Verification Snapshot
IRS EO Business Master File Status
Listed as tax-exempt
IRS Pub 78 Status
Eligible for tax-deductible gifts
IRS Revocation Status
Not in Automatic Revocation of Exemption List
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
plg-image
plg-image
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Total No. of Grants

10

Median grant size
$350K
Largest grant received
$2M
G
Grant Mitchell
Board Member
D
David Fajgenbaum
Board Member
F
Freda Lewis-Hall
Board Member

Frequently Asked Questions

What is EVERY CURE INC’s budget?
In 2024, EVERY CURE INC reported an annual operating budget of around $5.3 million. More detailed financial information is available to registered users.
What causes does EVERY CURE INC support?
EVERY CURE INC supports work in Public health and Medical research.
Where does EVERY CURE INC operate?
EVERY CURE INC is headquartered in Philadelphia, PA.
Who funded EVERY CURE INC recently?
In 2025, EVERY CURE INC received grants from Erasca Foundation, THE GOLDSTONE FUND INC, and THE CARL VICTOR PAGE MEMORIAL FOUNDATION. More information on this organization’s funders is available to registered users.
What is the largest grant EVERY CURE INC received in 2024?
The largest grant to EVERY CURE INC in 2024 exceeds $2 million.
What is EVERY CURE INC’s reliance on government grants?
EVERY CURE INC relied on government grants for more than 15% of their total revenue in 2024.
Overview
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)